| abstract |
The present invention relates to new sulfonamide URAT-1 inhibitor compounds of formula (I) or pharmaceutically acceptable salts thereof: n n n n n n n n n n to compositions containing them, to processes for their preparation and to intermediates used in such processes and to methods of treatment; wherein R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are as defined in the description. |